1. Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells
    Yan Li et al, 2017, Molecular Medicine Reports CrossRef
  2. Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer
    Li-rui Sun et al, 2019, Frontiers in Oncology CrossRef
  3. Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway
    Shibo Wu et al, 2020, Journal of International Medical Research CrossRef
  4. Anti-melanoma activity of Bupleurum chinense , Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-d
    Stephen Chu-Sung Hu et al, 2016, Journal of Ethnopharmacology CrossRef
  5. Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular Carcinoma
    Maryam Farzaneh et al, 2022, Current Cancer Therapy Reviews CrossRef
  6. Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice
    Min Hee Yang et al, 2024, MedComm CrossRef
  7. Chemotherapeutic Potential of Saikosaponin D: Experimental Evidence
    Suryaa Manoharan et al, 2022, Journal of Xenobiotics CrossRef
  8. Saponins from Chinese Medicines as Anticancer Agents
    Xiao-Huang Xu et al, 2016, Molecules CrossRef
  9. A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications
    Bochuan Yuan et al, 2017, Pharmaceutical Biology CrossRef
  10. Does herbal medicine reduce the risk of hepatocellular carcinoma?
    Yasushi Rino, 2015, World Journal of Gastroenterology CrossRef
  11. Comparative Effect of Aqueous and Methanolic Bupleuri Radix Extracts on Hepatic Uptake of High-Density Lipoprotein and Identification of the Potential Target in HFD-Fed Mice
    Zhibin Tan et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  12. Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese Medicine
    Sizhe Liu et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
  13. Advances in the anti-tumor mechanisms of saikosaponin D
    Ruixue Jia et al, 2024, Pharmacological Reports CrossRef
  14. Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown
    Yingtong Lv et al, 2019, Molecules CrossRef
  15. Present and Future Prospects of the Anti-cancer Activities of Saikosaponins
    Zuo-Yi Jiao et al, 2023, Current Cancer Drug Targets CrossRef
  16. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
    Devarajan Nalini et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
  17. Participation of HIFs in the regulation of Sertoli cell lactate production
    María Noel Galardo et al, 2017, Biochimie CrossRef
  18. Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling
    Hui He et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef
  19. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins
    Xiaojiaoyang Li et al, 2018, Phytomedicine CrossRef
  20. Saikosaponin-d Inhibits the Hepatoma Cells and Enhances Chemosensitivity Through SENP5-Dependent Inhibition of Gli1 SUMOylation Under Hypoxia
    Chun-Yan Zhang et al, 2019, Frontiers in Pharmacology CrossRef

  21. HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases


    Ruo-Lan Li et al, 2020, Drug Design, Development and Therapy CrossRef
  22. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
    Piao Zhou et al, 2021, Pharmaceutical Biology CrossRef
  23. Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action
    Mudan Ren et al, 2019, Frontiers in Pharmacology CrossRef
  24. The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases
    Byeong Mo Kim, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  25. Acertannin prevents azoxymethane/dextran sulfate sodium-induced colon cancer growth by inhibiting the colonic expression of interleukin-1β, monocyte chemoattractant protein-1, cyclooxygenase-2, and thymocyte selection-associated high mobility group box proteins (TOX)/TOX2 in C57BL/6J mice
    Yoshiyuki Kimura et al, 2023, European Journal of Pharmacology CrossRef
  26. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling
    Jixia Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  27. A comprehensive review of bupleuri radix and its bioactive components： with a major focus on treating chronic liver diseases
    Ying Zhong et al, 2024, Journal of Ethnopharmacology CrossRef